Last modified: November 10, 2021
Board Certified in General Surgery, Thoracic Surgery & Cardiac Surgery
About Dr. Velotta
Thoracic surgeon Dr. Jeffrey Velotta at Kaiser Permanente Oakland Medical Center treats mesothelioma patients along the West Coast. He also serves as a clinical assistant professor in the Department of Surgery at the University of California San Francisco School of Medicine.
After graduating from George Washington University School of Medicine, Velotta returned to his Bay Area roots in California for a general surgery residency at the University of California Los Angeles Medical Center.
He finished a postdoctoral cardiothoracic surgery research fellowship at Stanford University School of Medicine, then completed fellowship training in cardiothoracic surgery at Brigham and Women’s Hospital, Harvard Medical School. He is certified in general surgery from the American Board of Surgery and certified in thoracic surgery and cardiac surgery from the American Board of Thoracic Surgery.
Velotta has experience in all aspects of thoracic surgery. He focuses his work on minimally invasive lung and esophageal surgery, image-guided surgical techniques for small lung nodules and multimodality mesothelioma care.
“I currently have ongoing studies pertaining to novel ways to provide better pain relief after thoracic surgery and multimodality treatment of mesothelioma,” Velotta said.
Along with his wife, an internal medicine physician at Kaiser Permanente, he remains committed to providing excellent care and the best surgical services for mesothelioma patients.
Role as Medical Reviewer on Asbestos.com
Velotta’s expertise in thoracic surgery and his mesothelioma research work qualifies him to be an expert reviewer for The Mesothelioma Center at Asbestos.com. Thanks to his reviews, medical information remains factually correct and consistent across Asbestos.com.
By reviewing pages for medical accuracy and clarity, Velotta ensures the subject matter and medical content on Asbestos.com meet informational and scientific benchmarks regarding current standards of treatment for asbestos-related diseases.